Collagen Peptides Market Size and Share
Collagen Peptides Market Analysis by Mordor Intelligence
The global collagen peptides market size is expected to reach USD 2.74 billion in 2025 and USD 4.32 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.53% during the forecast period. This growth is driven by aging populations, increased focus on preventive healthcare, and rising consumer interest in beauty-enhancing supplements. The market demonstrates strength through its diverse applications, expanding from traditional pharmaceutical uses into sports nutrition and cosmeceuticals, segments that support higher price points. The aging demographic trend significantly influences market growth, as older consumers seek products that support joint health, skin elasticity, and bone strength. The preventive healthcare movement has positioned collagen supplements as essential components in daily wellness routines, particularly among health-conscious consumers. Additionally, the beauty-from-within trend has catalyzed demand for collagen-infused products across multiple categories, including beverages, supplements, and functional foods.
Key Report Takeaways
- By source, bovine dominated the collagen peptides market with a 42.13% share in 2024, while marine sources are expected to grow at a 9.11% CAGR through 2030.
- By form, dry powder accounted for 78.32% of the collagen peptides market in 2024, with liquid forms growing at an 8.26% CAGR through 2030.
- By application, the food and beverages segment generated 32.16% of revenue in 2024, while the cosmetics and personal care segment is expected to grow at an 8.08% CAGR during 2025-2030.
- By geography, North America held 37.65% of global sales in 2024, with Asia-Pacific projected to grow at a 9.43% CAGR through 2030.
Global Collagen Peptides Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising demand for nutraceuticals and functional foods | +1.8% | Global, with concentration in North America and Europe | Medium term (2-4 years) |
| Beauty-from-within trend in cosmeceuticals | +1.5% | Asia-Pacific core, spill-over to North America and Europe | Short term (≤ 2 years) |
| Aging population focus on bone and skin health | +1.2% | Global, particularly developed markets | Long term (≥ 4 years) |
| Expansion of sports-nutrition SKUs with collagen | +0.9% | North America and Europe, expanding to Asia-Pacific | Medium term (2-4 years) |
| Preference for natural and clean-label ingredients | +0.7% | Global, led by North America and Europe | Medium term (2-4 years) |
| Shift toward preventive healthcare | +0.6% | Global, with early adoption in developed markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising demand for nutraceuticals and functional foods
The nutraceutical market's adoption of collagen peptides indicates a shift from treating health issues to preventing them. Clinical studies demonstrating collagen's effectiveness in managing blood glucose levels have become an important market driver. Darling Ingredients' Nextida GC™ demonstrated a 42% reduction in post-meal blood glucose spikes in clinical trials, positioning collagen beyond traditional joint health into metabolic wellness applications. This metabolic angle opens premium pricing opportunities in functional beverages and meal replacement products, where collagen's protein content and bioactive peptides address both satiety and glycemic control. The convergence of aging demographics with preventive healthcare adoption creates sustained demand growth, particularly as healthcare systems increasingly recognize nutrition's role in chronic disease prevention. Functional food manufacturers are capitalizing on this trend by incorporating collagen into everyday products like dairy alternatives and snack bars, normalizing consumption patterns beyond traditional supplement formats.
Beauty-from-within trend in cosmeceuticals
The cosmeceutical segment's rapid expansion reflects consumer sophistication around collagen's dual-action benefits, where topical applications combine with oral supplementation to address skin aging at multiple levels. Clinical studies demonstrate that collagen peptide supplementation significantly improves skin elasticity and reduces wrinkle formation, with 83.6% of participants showing measurable improvements in global wrinkle scores over 3-month periods. This evidence-based approach distinguishes collagen from cosmetic ingredients lacking clinical validation, creating premium positioning opportunities. The K-beauty influence amplifies this trend, with South Korean companies like Huons N expanding into European markets with collagen-infused konjac jellies that combine beauty benefits with meal replacement functionality. The beauty-from-within concept resonates particularly with millennials and Gen Z consumers who prioritize holistic wellness approaches over traditional cosmetic solutions. Marine collagen's superior bioavailability and lower molecular weight enhance absorption rates, making it the preferred choice for cosmeceutical applications where visible results drive repeat purchases.
Aging population focus on bone and skin health
The global shift toward aging populations drives consistent demand for collagen supplementation, supported by clinical evidence of its effectiveness in managing age-related conditions such as osteoporosis and joint degeneration. The World Health Organization projects that the global population aged 60 and older will increase from 1.1 billion in 2023 to 1.4 billion by 2030[1]Source: World Health Organization, "Ageing: Global population," who.int. Clinical studies show that daily intake of 5-gram collagen peptides improves bone mineral density over periods ranging from 12 months to 4 years, with no documented fractures or adverse effects. This medical validation transforms collagen from a dietary supplement into a therapeutic option, expanding its distribution through pharmaceutical channels and medical professionals. Unlike younger consumers who may use collagen occasionally for cosmetic purposes, older populations maintain regular consumption patterns to preserve independence and quality of life. Research indicates that undenatured type II collagen aids in arthritis management through gut-joint homeostasis restoration and immune response regulation, expanding its potential therapeutic uses. Healthcare systems increasingly support collagen-based interventions through favorable reimbursement policies, recognizing that preventive nutrition is more cost-effective than treating chronic diseases.
Expansion of sports-nutrition SKUs with collagen
The sports nutrition market increasingly incorporates collagen due to its distinct amino acid composition, which complements traditional protein sources like whey and casein. Collagen's high concentrations of glycine and proline support connective tissue repair and muscle recovery, aligning with the market's evolution from focusing solely on muscle development to comprehensive performance enhancement. This differentiation allows manufacturers to position collagen-based products at premium price points in pre-workout and recovery formulations. The market expansion includes functional beverages and protein bars, providing convenient consumption options for active consumers. Marine collagen's neutral flavor characteristics enable manufacturers to incorporate it into existing product lines without compromising taste. The growing preference for clean-label ingredients in sports nutrition products benefits collagen, as athletes increasingly focus on natural ingredient sources and processing methods. The market growth extends beyond professional athletes to recreational fitness enthusiasts, who adopt similar nutrition strategies, thereby expanding the consumer base.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High production cost and raw-material price swings | -1.4% | Global, particularly affecting smaller manufacturers | Short term (≤ 2 years) |
| Cultural/religious limits on animal sources | -0.8% | Asia-Pacific and Middle East and Africa regions, with spillover to global markets | Medium term (2-4 years) |
| Rise of recombinant and plant-based collagen analogues | -0.6% | Global, with early adoption in developed markets | Long term (≥ 4 years) |
| Marine-source supply chain fragility | -0.5% | Global, concentrated in regions dependent on marine collagen | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High production cost and raw-material price swings
Production cost volatility emerges as the primary constraint limiting collagen peptides market expansion, particularly affecting smaller manufacturers who lack economies of scale and supply chain integration. Raw material price fluctuations reflect broader agricultural and marine commodity cycles, where bovine hide prices correlate with beef production volumes and marine collagen costs depend on fishing industry byproduct availability. This volatility creates margin pressure for manufacturers who cannot pass costs to price-sensitive consumer segments, forcing consolidation toward larger players with vertical integration capabilities. The challenge intensifies for premium marine collagen, where limited raw material sources and specialized processing requirements create supply bottlenecks that smaller companies cannot navigate effectively. Processing complexity adds another cost layer, as collagen extraction requires specialized equipment and quality control systems that represent significant capital investments for new market entrants. The industry's response includes backward integration strategies and long-term supply agreements, though these approaches favor established players over emerging competitors seeking market share through innovation.
Cultural and religious limits on animal sources
Religious and cultural restrictions on animal-derived collagen create market access barriers, particularly in regions where bovine and porcine sources face limitations. This drives demand for marine collagen alternatives, though supply constraints and higher processing costs affect adoption in price-sensitive markets. Recombinant and plant-based collagen alternatives address these restrictions but face challenges in consumer acceptance and regulatory approvals. Companies such as Evonik have developed fermentation-based collagen platforms that avoid animal-derived materials while maintaining functionality. These constraints affect both direct sales and supply chain operations, requiring manufacturers to maintain separate production lines and quality systems for different source materials. The market has become fragmented as companies develop region-specific product portfolios, increasing operational costs and reducing economies of scale.
Segment Analysis
By Source: Marine Collagen Drives Premium Positioning
Marine collagen is projected to grow at a CAGR of 9.11% through 2030, driven by its effectiveness in premium applications. However, bovine collagen maintains market leadership with a 42.13% share in 2024. The marine segment benefits from enhanced bioavailability and lower molecular weight compared to terrestrial sources, making it the preferred choice for cosmeceutical applications where absorption rates directly impact efficacy. Bovine collagen maintains market leadership through established supply chains and cost advantages, particularly in food and beverage applications where functional properties matter more than premium positioning. Porcine collagen faces cultural and religious restrictions that limit global expansion, while poultry collagen represents an emerging segment with potential for growth in regions seeking alternative protein sources.
Thai Union's USD 30 million investment in marine collagen processing demonstrates the segment's commercial viability, with their ThalaCol product derived from tuna skin offering unique differentiation from commonly used cod sources. The marine segment's growth trajectory benefits from sustainability positioning, where the utilization of fish processing byproducts aligns with circular economy principles and reduces environmental waste. However, supply chain fragility remains a concern, as marine collagen depends on fishing industry byproducts that can fluctuate based on catch volumes and processing capacity constraints.
Note: Segment shares of all individual segments available upon report purchase
By Form: Liquid Formulations Gain Convenience Premium
Liquid collagen formulations are growing at 8.26% CAGR, while dry forms maintain a dominant 78.32% market share in 2024. This growth reflects increasing consumer preference for convenience and the perception of better absorption. The liquid segment maintains higher price points due to its enhanced bioavailability and ready-to-consume formats, particularly appealing to sports nutrition and beauty segments where immediate consumption is valued. Dry formulations continue to offer cost advantages and extended shelf life, making them preferred for bulk applications and price-sensitive markets.
The manufacturing requirements for liquid formulations create market entry barriers in premium segments, benefiting established manufacturers through protected margins. While the dry segment leverages existing supply chains and processing infrastructure, ongoing improvements in powder technology and flavor masking enhance consumer acceptance. Liquid formulations require specialized stability measures and preservation methods, including advanced packaging and cold chain distribution, which increases operational costs. The segment's expansion aligns with the growing demand for functional beverages and ready-to-drink supplements, where collagen adds protein content and health benefits, creating product differentiation in competitive markets.
By Application: Cosmetics Accelerates Beyond Traditional Uses
Cosmetics and personal care applications are growing at 8.08% CAGR, challenging the food and beverages segment's dominant 32.16% market share in 2024. The cosmetics segment's growth stems from scientific validation of collagen's skin health benefits, with documented improvements in skin elasticity and wrinkle reduction driving consumer retention. Food and beverage applications maintain market leadership through functional ingredient integration, incorporating collagen to enhance protein content and nutritional value in products like dairy products and snack bars.
The nutraceuticals and dietary supplements segment shows moderate growth as it matures and competes with functional foods that incorporate collagen into daily consumption. The pharmaceutical and medical segment demonstrates potential in specialized areas, particularly tissue engineering and wound healing, leveraging collagen's biocompatibility and biodegradability. Animal nutrition and pet food applications expand through pet care premiumization, with collagen supplements reflecting human health applications and corresponding price points.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America accounts for 37.65% of the global market share in 2024, supported by established supplement distribution networks and comprehensive FDA regulatory frameworks. The region's consumers show strong awareness of collagen benefits and willingness to pay premium prices, especially in sports nutrition and anti-aging categories. The FDA's guidelines on new dietary ingredients provide a clear regulatory environment that facilitates product development and market growth[2]Source: U.S. Food & Drug Administration, “Revised Draft Guidance for New Dietary Ingredient Notifications,” fda.gov. However, limited local bovine collagen production creates supply chain vulnerabilities, exposing manufacturers to trade disruptions and currency fluctuations. North American companies are developing recombinant and plant-based alternatives, which could decrease import dependency in the future.
Asia-Pacific is projected to grow at a CAGR of 9.43% through 2030, making it the fastest-growing region in the market. This growth is primarily driven by the expanding middle-class population, the influence of Korean beauty trends, and investments in marine collagen processing facilities. Countries like Thailand utilize fishing industry byproducts for collagen production, exemplified by Thai Union's USD 30 million facility investment. South Korean companies are entering international markets with products such as collagen-infused konjac jellies, which appeal to European consumers influenced by Korean beauty trends. The region's diverse religious and dietary requirements create opportunities for marine and plant-based collagen alternatives, while limiting the market potential for traditional animal-derived products in specific markets.
Europe maintains growth through its premium market positioning and regulatory frameworks that support innovation while ensuring consumer protection. The European Food Safety Authority's updated novel food guidance provides clarity for emerging collagen applications[3]Source: European Food Safety Authority, “Updated Guidance on Novel Foods,” efsa.europa.eu. The region's emphasis on sustainability and circular economy principles creates favorable conditions for marine collagen and alternative protein sources. The established pharmaceutical and cosmetics industries provide robust distribution channels for premium products. South America and the Middle East and Africa present growth opportunities in the collagen peptides market. However, market development in these regions requires investment in distribution infrastructure and consumer education about collagen benefits. The regulatory frameworks in these regions are evolving to accommodate innovative collagen applications.
Competitive Landscape
The collagen peptides market exhibits moderate fragmentation with a level 5 out of 10 rating, indicating balanced competition between established players and emerging innovators who leverage technological differentiation and niche positioning strategies. Traditional leaders like GELITA AG and Darling Ingredients maintain market share through vertical integration and established supply chains, while newer entrants focus on premium segments like marine collagen and recombinant alternatives, where innovation commands pricing premiums.
The competitive dynamic reflects industry maturation, where scale advantages in raw material procurement and processing compete with specialized capabilities in emerging applications like 3D bioprinting and precision fermentation. Companies are increasingly pursuing backward integration strategies to secure raw material supplies and reduce cost volatility, while simultaneously investing in R&D capabilities to develop next-generation collagen alternatives that address cultural, religious, and sustainability concerns.
Strategic patterns emphasize geographic expansion and application diversification, where companies leverage core competencies in collagen processing to enter adjacent markets like cosmeceuticals and functional foods. Evonik's development of fermentation-based collagen platforms exemplifies technology-driven differentiation, where animal-free production addresses market constraints while maintaining functional properties required for medical and pharmaceutical applications. White-space opportunities exist in therapeutic applications where collagen's biocompatibility and biodegradability provide clinical advantages, particularly in tissue engineering and regenerative medicine where regulatory approval creates sustainable competitive moats.
Collagen Peptides Industry Leaders
-
GELITA AG
-
Darling Ingredients
-
Nitta Gelatin Inc.
-
PB Leiner
-
Weishardt Group
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- June 2025: Thai Union invested USD 30 million in a new marine collagen processing facility in Thailand, introducing ThalaCol, a product derived from tuna skin, to serve premium collagen markets in Asia. This investment enables the company to diversify into high-value byproduct processing and meet the increasing demand for marine collagen in beauty and healthy aging applications.
- May 2024: Nitta Gelatin India launched a ₹60 crore expansion project in Kerala focused on collagen peptide production, part of a larger ₹200 crore investment commitment. The expansion responds to growing global demand for collagen supplements and includes development of new variants for diabetes management applications.
Global Collagen Peptides Market Report Scope
| Bovine |
| Porcine |
| Marine |
| Poultry |
| Others |
| Dry |
| Liquid |
| Food and Beverages | Functional Beverages |
| Snacks and Bars | |
| Dairy and Confectionery | |
| Others | |
| Nutraceuticals/Dietary Supplements | |
| Cosmetics and Personal Care | |
| Pharmaceuticals and Medical | |
| Animal Nutrition and Pet Food |
| North America | United States |
| Canada | |
| Mexico | |
| Rest of North America | |
| Europe | Germany |
| United Kingdom | |
| Italy | |
| France | |
| Spain | |
| Netherlands | |
| Poland | |
| Belgium | |
| Sweden | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| Australia | |
| Indonesia | |
| South Korea | |
| Thailand | |
| Singapore | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Colombia | |
| Chile | |
| Peru | |
| Rest of South America | |
| Middle East and Africa | South Africa |
| Saudi Arabia | |
| United Arab Emirates | |
| Nigeria | |
| Egypt | |
| Morocco | |
| Turkey | |
| Rest of Middle East and Africa |
| By Source | Bovine | |
| Porcine | ||
| Marine | ||
| Poultry | ||
| Others | ||
| By Form | Dry | |
| Liquid | ||
| By Application | Food and Beverages | Functional Beverages |
| Snacks and Bars | ||
| Dairy and Confectionery | ||
| Others | ||
| Nutraceuticals/Dietary Supplements | ||
| Cosmetics and Personal Care | ||
| Pharmaceuticals and Medical | ||
| Animal Nutrition and Pet Food | ||
| Segmentation by Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Rest of North America | ||
| Europe | Germany | |
| United Kingdom | ||
| Italy | ||
| France | ||
| Spain | ||
| Netherlands | ||
| Poland | ||
| Belgium | ||
| Sweden | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| Australia | ||
| Indonesia | ||
| South Korea | ||
| Thailand | ||
| Singapore | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| Chile | ||
| Peru | ||
| Rest of South America | ||
| Middle East and Africa | South Africa | |
| Saudi Arabia | ||
| United Arab Emirates | ||
| Nigeria | ||
| Egypt | ||
| Morocco | ||
| Turkey | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What is the current value of the collagen peptides market?
The collagen peptides market size stood at USD 2.74 billion in 2025 and is projected to hit USD 4.32 billion by 2030.
Which source dominates global supply?
Bovine collagen retained 42.13% of collagen peptides market share in 2024, supported by cost-efficient hide rendering networks.
Why is marine collagen growing faster than bovine?
Marine collagen peptides, with their lower molecular weight that enables enhanced absorption and compatibility with various cultural dietary requirements, are projected to grow at a CAGR of 9.11% through 2030.
Which region is expanding the quickest?
Asia-Pacific is forecast to grow at 9.43% annually to 2030 on rising incomes, K-beauty trends and new marine-collagen plants.
Page last updated on: